Nu Skin Enterprises, Inc. (NUS) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Nu Skin Enterprises, Inc. (NUS) Consumer Business Overview

Nu Skin Enterprises develops and distributes beauty and wellness products, emphasizing skincare and nutritional supplements. With a direct-selling model and a global presence, the company competes in the household and personal products sector, balancing innovation with market demand and regulatory changes.

What Is the Investment Thesis for NUS?

Nu Skin Enterprises, Inc. presents a mixed investment profile. With a P/E ratio of 4.73 and a dividend yield of 3.35%, the company offers potential value and income. However, a relatively low profit margin of 3.8% indicates challenges in profitability. Key growth catalysts include expansion in emerging markets and continued innovation in skincare and nutritional products. The company's direct selling model faces risks from changing consumer preferences and regulatory scrutiny. Investors should monitor Nu Skin's ability to adapt to these challenges and capitalize on its brand recognition and global distribution network.

Based on FMP financials and quantitative analysis

NUS Key Highlights

Market Cap of $237M reflects its current valuation in the beauty and wellness market.

• P/E Ratio of 4.73 indicates potential undervaluation compared to industry peers.
• Gross Margin of 69.3% demonstrates strong pricing power and efficient cost management.
• Dividend Yield of 3.35% provides an attractive income stream for investors.
• Beta of 1.07 suggests the stock's volatility is slightly higher than the market average.

Who Are NUS's Competitors?

NUS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are NUS's Key Strengths?

Strong brand recognition in the beauty and wellness industry.

• Proprietary ageLOC technology.
• Established global distribution network.
• Direct selling model providing direct customer engagement.

What Are NUS's Weaknesses?

Reliance on direct sales model, which can be vulnerable to regulatory changes.

• Relatively low profit margin compared to some competitors.
• Geographic concentration in certain markets, particularly Mainland China.
• Potential for negative publicity related to direct selling practices.

What Could Drive NUS Stock Higher?

Launch of new skincare and nutritional products in Q3 2026.

• Expansion of e-commerce platform and digital marketing initiatives.
• Strategic partnerships to expand product portfolio and market reach.

What Are the Key Risks for NUS?

Negative return on equity (-29.4%) — the business is not currently generating profit on shareholder capital.

• Regulatory changes impacting direct selling practices.
• Economic downturns affecting consumer spending on discretionary items.
• Intense competition from established and emerging brands.
• Fluctuations in currency exchange rates impacting international sales.

What Are the Growth Opportunities for NUS?

• Expansion in Emerging Markets: Nu Skin has the opportunity to expand its presence in emerging markets, particularly in Asia, where demand for beauty and wellness products is rapidly growing. By tailoring its product offerings and marketing strategies to local preferences, Nu Skin can tap into new customer segments and drive revenue growth. The market size for beauty and wellness products in Asia is estimated to reach $500 billion by 2030, presenting a significant growth opportunity for Nu Skin.
• Product Innovation in Skincare: Nu Skin can capitalize on the growing demand for advanced skincare solutions by investing in research and development and launching innovative products. The company's ageLOC technology provides a competitive advantage in the anti-aging market. The global skincare market is projected to reach $180 billion by 2028, driven by increasing awareness of skincare benefits and the availability of advanced products.
• Digital Transformation and E-commerce: Nu Skin can enhance its online presence and e-commerce capabilities to reach a broader customer base and improve the customer experience. By investing in digital marketing, social media engagement, and online sales platforms, Nu Skin can drive online sales and reduce its reliance on direct sales channels. The global e-commerce market for beauty and wellness products is expected to reach $100 billion by 2027.
• Strategic Partnerships and Acquisitions: Nu Skin can pursue strategic partnerships and acquisitions to expand its product portfolio, enter new markets, and gain access to new technologies. By partnering with complementary businesses, Nu Skin can leverage synergies and accelerate its growth. The company could explore opportunities in personalized nutrition, wellness technology, and sustainable beauty.
• Personalized Nutrition and Wellness: Nu Skin can leverage the growing trend towards personalized nutrition and wellness by offering customized product recommendations and solutions based on individual needs and preferences. By collecting data on customer health and lifestyle, Nu Skin can develop targeted products and services that address specific health concerns.

What Are NUS's Competitive Advantages?

• Brand recognition and reputation in the beauty and wellness market.
• Proprietary ageLOC technology providing a competitive advantage in anti-aging.
• Established direct sales network and distributor relationships.
• Global distribution network reaching customers in multiple countries.

What Does NUS Do?

Founded in 1984 and headquartered in Provo, Utah, Nu Skin Enterprises, Inc. develops and distributes an extensive range of beauty and wellness products worldwide. The company's offerings include advanced skin care systems like the ageLOC Spa and ageLOC Transformation, along with devices such as the ageLOC LumiSpa. These products target anti-aging and skin treatment needs. In addition to skincare, Nu Skin provides nutritional supplements, including the ageLOC Youth and LifePak lines, and weight management systems like ageLOC TR90. The company also offers the Beauty Focus Collagen+ supplement. Nu Skin operates retail stores and service centers, particularly in Mainland China, and sells its products through direct sales, distributors, and its website. The company's brands include Nu Skin, Pharmanex, and ageLOC, reflecting its commitment to both beauty and wellness sectors. Nu Skin continues to invest in research and product development to stay competitive and meet evolving consumer demands.

What Products and Services Does NUS Offer?

• Develop and distribute skincare systems targeting anti-aging and skin treatment.
• Offer nutritional supplements focused on overall wellness and specific health benefits.
• Provide weight management and body shaping systems.
• Operate retail stores and service centers in select markets.
• Engage in research and product development for skincare and nutritional products.
• Sell products through direct sales, distributors, and online channels.

How Does NUS Make Money?

• Direct sales model leveraging distributors to reach customers.
• Online sales through the company's website.
• Retail operations in specific markets, particularly Mainland China.
• Subscription-based programs for recurring revenue.

What Industry Does NUS Operate In?

Nu Skin operates in the competitive household and personal products industry, characterized by evolving consumer preferences and intense competition. The global beauty and wellness market is driven by increasing disposable incomes and a growing emphasis on personal care. Nu Skin's direct selling model differentiates it from traditional retail brands, but also exposes it to unique regulatory and operational challenges. The company must continuously innovate and adapt to maintain its market position amid changing trends and competitive pressures.

Who Are NUS's Key Customers?

• Individuals seeking anti-aging and skincare solutions.
• Consumers interested in nutritional supplements and wellness products.
• Customers looking for weight management and body shaping systems.
• Distributors who sell Nu Skin products to their networks.

Company Profile

Nu Skin Enterprises, Inc. operates in the Household & Personal Products industry within the Consumer Defensive sector. It is headquartered in Provo, US. The company is led by CEO Ryan S. Napierski. NUS has traded publicly since 1996.

Nu Skin Enterprises, Inc. Financial Trajectory

Nu Skin Enterprises, Inc. (NUS) reported $320.1M in revenue for Q2 FY2026, a decline of 0.2% compared to the prior quarter. The company recorded a net loss of $249.8M, with diluted EPS of $-5.14. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Consumer Defensive stock should monitor closely. Across the four most recent quarters, NUS averaged $-1.12 in diluted EPS.

How Nu Skin Enterprises, Inc. Is Valued

Nu Skin Enterprises, Inc. carries a market capitalization of $237M, placing it in the micro-cap category. Relative to its peer group, NUS's quantitative score of 48/100 is roughly in line with the peer average of 57/100.

Return on equity for Nu Skin Enterprises, Inc. stands at -29.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -19.3%, showing how much profit it generates from its asset base. Its free cash flow yield is 4.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.98 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -92.9%, the inverse of the P/E and a quick read on earnings relative to price.

Nu Skin Enterprises, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.71 places it in the safe zone, indicating low near-term bankruptcy risk.

Nu Skin Enterprises, Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 21.5% above estimates on average.

Over the past six months, Nu Skin Enterprises, Inc. insiders filed 2 SEC Form 4 transactions — 1 sales and 1 purchases. On net that is roughly 3K shares disposed (about $18K), a signal worth weighing alongside the fundamentals.

NUS Financials

NUS Latest News

NUS Analyst Consensus

NUS MoonshotScore

NUS Consumer Defensive Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources